Abstract:The present work models plutonium (Pu) biokinetics in a female former nuclear worker. Her bioassay measurements are available at the US Transuranium and Uranium Registries. The worker was internally exposed to a plutonium-americium mixture via acute inhalation at a nuclear weapons facility. She was medically treated with injections of 1 g Ca-DTPA on days 0, 5, and 14 after the intake. Between days 0 and 20, fecal and urine samples were collected and analyzed for 239Pu and 241Am. Subsequently, she was followed up for bioassay monitoring over 14 y, with additional post-treatment urine samples collected and analyzed for 239Pu. The uniqueness of this dataset is due to the availability of: (1) both early and long-term bioassay data from a female with plutonium intake; (2) data on chelation therapy for a female; and (3) fecal measurement results. Chelation therapy with Ca- and/or Zn-salts of DTPA is known to aid in reducing the internal radiation dose by enhancing the excretion of plutonium and americium from the body. Such enhancement affects plutonium biokinetics in the human body, posing a challenge to the internal dose assessment. The current radiation dose assessment practice is to exclude the data affected by Ca-DTPA from the analysis. The present analysis is the first to explicitly model the chelation-affected bioassay data in a female by using a newly developed chelation model. Thus, the bioassay data collected during and after the Ca-DTPA administrations were used for biokinetic modeling and dose assessment. The Markov Chain Monte Carlo method was used to investigate model parameter uncertainty, based on the bioassay data and assumed prior probability distributions. A χ2/nData (number of data points) ≈ 1 was observed in this study, which indicates self-consistency of the data with the model. Results of this study show that the worker's 239Pu intake was 12 Bq, with a committed effective dose to the whole-body of 1.2 mSv and a committed equivalent dose to the bone surfaces, liver, and lungs of 37.8, 9.1, and 0.8 mSv, respectively. This study also discusses the worker's dose reduction due to chelation treatment.

Plutonium in [99mTc] Pertechnetate for clinical use: concise communication

A Rapid Method for Quantification OF 242Pu in Urine Using Extraction Chromatography and ICP-MS

Determination of Plutonium Isotopes (Pu-238, Pu-239, Pu-240, Pu-241) in Environmental Samples Using Radiochemical Separation Combined with Radiometric and Mass Spectrometric Measurements

Biophysical aspects of Am-241 and Pu-241 in the environment

Altered [99mTc]Tc-MDP biodistribution from neutron activation sourced 99Mo

Comparison for the simultaneous determination of 237Np and Pu isotopes between TEVA and TK200 resin

Estimation of 241Am and 239Pu activity embedded in the tissue using portable planar HPGe detector

240Pu/239Pu isotopic ratio measurements in micrometric Pu and MOX particles using Secondary Ion Mass Spectrometry

Activities of Pu and Am isotopes and isotopic ratios in a soil contaminated by weapons-grade plutonium

Determination of Pu-239 content in Pu–Be neutron sources using Gamma-ray spectrometry

Fusion-Based Neutron Generator Production of Tc-99m and Tc-101: A Prospective Avenue to Technetium Theranostics

Disposition of plutonium-239 via production of fission molybdenum-99

Determination of Plutonium Isotopes (238pu, 239pu, 240pu, 241pu) in Environmental Samples Using Radiochemical Separation Combined with Radiometric and Mass Spectrometric Measurements

Non-destructive assay of plutonium in absence of gamma-ray spectrometry

Alpha spectrometry and liquid scintillation counting for the measurement of 238Pu, 239Pu, 240Pu, 241Pu, 242Pu and age

Molybdenum-99 from Molten Salt Reactor as a Source of Technetium-99m for Nuclear Medicine: Past, Current, and Future of Molybdenum-99

Modeling Plutonium Decorporation in a Female Nuclear Worker Treated with Ca-DTPA after Inhalation Intake

Reaching environmental levels of 244Pu by accelerator mass spectrometry at the Centro Nacional de Aceleradores

The Shortage of Technetium-99m and Possible Solutions

Rapid Determination of Ultra-Trace Plutonium Isotopes (239pu, 240pu and 241pu) in Small-Volume Human Urine Bioassay Using Sector-Field Inductively Coupled Plasma Mass Spectrometry.

A multi-collector ICP-MS method for quantification of plutonium, uranium, and americium in hair and nails of occupationally or medically exposed individuals